AMIX Autonomix Medical, Inc. stock chart & analysis
Conviction 36HealthcareScan · Mon, Nov 9, 2026Autonomix Medical, Inc. (AMIX) closed at $1.68 (+10.53%) on Nov 9, 2026. Its latest daily candle is a morning star. Price is below its 50-day and below its 200-day moving average. RSI(14) 25, RS Rating 3, -94.6% from its 52-week high, -84.7% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.
Why AMIX moved
From the StockSetups movers recaps that covered AMIX, newest first. A recap states what was known that day.
- After hours+26.2%
Autonomix Medical jumped 26.2% after hours to $2.12 on 189,794 shares, over three times its 20-day average of 57,415. Market cap is only about $1.6M.
After-Hours Movers Nov 9, 2026: Why TANH, RUBI, AMIX Jumped → - Premarket+54.8%
The catalyst is clearly identified. MarketScreener reports that Autonomix Medical shares are surging pre-bell after a $4.9 million warrant inducement priced at a premium to market.
Premarket Stock Movers — August 25, 2026: Why AIXI, DAIC, SWVL, AMIX & TNMG Are Surging →
Financials as of Tue, Jun 30, 2026 · quarterly.
AMIX technical analysis
Trend
AMIX is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 49.3% below the 50-day ($3.32) and 73.5% below the 200-day ($6.34). ADX(14) at 33 points to a strong, established trend. It meets 0 of 8 trend-template criteria.
Momentum
RSI(14) is 25, in oversold territory. MACD crossed above its signal line on the latest session. A bullish MACD divergence is in place. Its RS Rating of 3 puts its weighted 12-month performance ahead of about 3% of the US market.
Volume and volatility
It trades about $118,071 a day on average. ATR(14) is $0.2344, 14.0% of price — its typical daily range. On-balance volume is trending down. Chaikin Money Flow (-0.70) shows distribution.
Key levels
The 52-week range is $1.46 to $31.00; price is 94.6% below the high and 15.1% above the low. The VWAP anchored at the 52-week high is $11.26, above price.
Performance
AMIX returned +0.0% (1 week), -46.0% (1 month), -81.6% (3 months), -75.0% (6 months), -90.2% (1 year), -84.7% (year to date).
About Autonomix Medical, Inc.
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
Surgical & Medical Instruments & Apparatus · Listed 2024 · 11 employees
Recent news
- Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural ValidationYahoo Finance · Fri, Oct 2, 2026
- Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. ClearanceYahoo Finance · Wed, Sep 30, 2026
- Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation PlatformYahoo Finance · Thu, Sep 24, 2026
- Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of DirectorsYahoo Finance · Wed, Sep 16, 2026
- A former Medtronic FDA lawyer joins Autonomix’s board after work on more than 27 acquisitions.Stock Titan · Wed, Sep 16, 2026
- Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026Yahoo Finance · Tue, Sep 1, 2026
- Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy DeliveryYahoo Finance · Wed, Aug 26, 2026
- Autonomix Medical patent covers systems for nerve ablation to reduce cancer painStock Titan · Wed, Aug 26, 2026
- Autonomix Medical (AMIX) Stock Surges 117% After Hours: Here’s WhyTradingView · Tue, Aug 25, 2026
- AMIX Stock Whipsaws As FDA Path, Patents And Financing CollideStocksToTrade · Tue, Aug 25, 2026
Insider activity
SEC Form 4 transactions in AMIX
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Smith Trent N. CFO · Common Stock · 2026-09-03 | Grant | 15K | — | 2026-09-03 | 2026-09-21 |
Hauser Bradley CEO and President · Common Stock · 2026-09-03 | Grant | 27K | — | 2026-09-03 | 2026-09-08 |
Bisson Lori Director · Common Stock · 2026-09-03 | Grant | 13K | — | 2026-09-03 | 2026-09-08 |
KLEMP WALTER V Director · Common Stock · 2026-09-03 | Grant | 13K | — | 2026-09-03 | 2026-09-08 |
SEC filings
EDGAR filings in AMIX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.